BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 4703828)

  • 21. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 22. The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves.
    Axelrod J; Kopin IJ
    Prog Brain Res; 1969; 31():21-32. PubMed ID: 4900113
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibition of norepinephrine release in nasal mucosa by acetylcholine.
    Jackson RT; Steele RW
    Rhinology; 1985 Mar; 23(1):59-64. PubMed ID: 4001760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by acetylcholine of the norepinephrine release evoked by potassium in canine saphenous veins.
    Vanhoutee PM; Verbeuren TJ
    Circ Res; 1976 Aug; 39(2):263-9. PubMed ID: 939012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of norepinephrine uptake by potassium ions in vascular smooth muscle.
    Vanhoutte PM; Lorenz RR
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):377. PubMed ID: 4852479
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Influence of halothane on peripheral sympathetic nerves and on the effects of noradrenaline on myocardium.
    Göthert M; Guth M; Bille U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R26. PubMed ID: 4276549
    [No Abstract]   [Full Text] [Related]  

  • 27. Prejunctional inhibition of norepinephrine release caused by acetylcholine in the human saphenous vein.
    Rorie DK; Rusch NJ; Shepherd JT; Vanhoutte PM; Tyce GM
    Circ Res; 1981 Aug; 49(2):337-41. PubMed ID: 7249270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of nicotine-induced release of norepinephrine from adrenergic nerve endings: does it act like tyramine?
    Jayasundar S; Vohra MM
    Indian J Exp Biol; 1977 Dec; 15(12):1218-9. PubMed ID: 614227
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effects of prostaglandins E 1 , E 2 , F 1 and F 2 on adrenergic vasoconstriction in the dog hindpaw.
    Kadowitz PJ; Sweet CS; Brody MJ
    J Pharmacol Exp Ther; 1971 Jun; 177(3):641-9. PubMed ID: 4328021
    [No Abstract]   [Full Text] [Related]  

  • 30. Innervation pattern and neurogenic response of rabbit veins.
    Bevan JA; Hosmer DW; Ljung B; Pegram BL; Su C
    Blood Vessels; 1974; 11(3):172-82. PubMed ID: 4451729
    [No Abstract]   [Full Text] [Related]  

  • 31. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

  • 32. The antagonism of phentolamine against exogenously administered and endogenously released norepinephrine in rabbit aortic strips.
    Urquilla PR; Stitzel RE; Fleming WW
    J Pharmacol Exp Ther; 1970 Apr; 172(2):310-9. PubMed ID: 4315002
    [No Abstract]   [Full Text] [Related]  

  • 33. Noradrenaline uptake properties of the anococcygeus muscle of the rat.
    Nash CW; Gillespie JS; Robertson EN
    Can J Physiol Pharmacol; 1974 Jun; 52(3):430-40. PubMed ID: 4853369
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of positive chronotropic response of the canine SA node to selective administration of ketamine.
    Nakajima T; Azumi T; Yatabe Y
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):247-56. PubMed ID: 708151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by acetylcholine of 3H-norepinephrine release in cutaneous veins after alpha-adrenergic blockade.
    Vanhoutte PM; Verbeuren TJ
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):344-6. PubMed ID: 9039
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on the response of canine mesenteric vein to noradrenaline and acetylcholine.
    O'Connor PC; Slater P
    J Physiol; 1972 Dec; 227(2):40P-41P. PubMed ID: 4647252
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of lithium on the adrenergic nerve ending.
    Beaty O; Collis MG; Shepherd JT
    J Pharmacol Exp Ther; 1981 Aug; 218(2):309-17. PubMed ID: 6265622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of moderate acidosis on adrenergic neurotransmission in canine saphenous veins.
    Verbeuren TJ; Janssens WJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1978 Jul; 206(1):105-14. PubMed ID: 207858
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions.
    Tranzer JP; Thoenen H; Snipes RL; Richards JG
    Prog Brain Res; 1969; 31():33-46. PubMed ID: 4900115
    [No Abstract]   [Full Text] [Related]  

  • 40. The sympathomimetic effect of gallamine on the heart.
    Brown BR; Crout JR
    J Pharmacol Exp Ther; 1970 Apr; 172(2):266-73. PubMed ID: 5441155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.